Vycor Medical Reports Q3 Revenue of $0.41 Million and Zero GAAP EPS
Vycor Medical (VYCO) has released its third-quarter financial results, reporting a GAAP earnings per share (EPS) of $0.00. The company's revenue for the quarter reached $0.41 million, representing a 19.6% decrease compared to the same period last year. The decline in year-over-year revenue suggests a contraction in top-line growth for the company during this fiscal period. Investors will be monitoring whether these results reflect broader market trends or specific operational challenges within the medical sector.

Tickers: $VYCO
Topics: earnings GAAP EPS revenue decline